Texas Yale Capital Corp’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-10,851
Closed -$232K – 435
2019
Q4
$232K Hold
10,851
– – 0.02% 425
2019
Q3
$249K Hold
10,851
– – 0.02% 407
2019
Q2
$214K Sell
10,851
-10,851
-50% -$211K 0.02% 432
2019
Q1
$422K Buy
21,702
+10,841
+100% +$205K 0.02% 419
2018
Q4
$179K Sell
10,861
-50
-0.5% -$1.01K 0.02% 402
2018
Q3
$252K Hold
10,911
– – 0.02% 407
2018
Q2
$237K Sell
10,911
-279
-2% -$5.45K 0.02% 410
2018
Q1
$198K Sell
11,190
-3,210
-22% -$56.6K 0.02% 433
2017
Q4
$270K Buy
14,400
+579
+4% +$11.5K 0.02% 408
2017
Q3
$303K Buy
+13,821
New +$312K 0.03% 390

Other funds holding SBRA

Texas Yale Capital Corp's SBRA Position: Q1 2020 in Review

Texas Yale Capital Corp sold out of Sabra Healthcare REIT (SBRA) in Q1 2020, closing a stake of 10,851 shares — an estimated $232K sold.

Texas Yale Capital Corp first reported a position in SBRA in Q3 2017 and held it in 10 quarters. The position peaked at $422K in Q1 2019. 323 funds tracked by Wall St. Rank hold SBRA as of Q1 2020.

  • Texas Yale Capital Corp reported no remaining Sabra Healthcare REIT position as of Q1 2020 after selling out during the quarter.
  • Texas Yale Capital Corp sold 10,851 Sabra Healthcare REIT shares in Q1 2020, an estimated $232K.
  • Texas Yale Capital Corp first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 10 quarters.
  • Texas Yale Capital Corp's Sabra Healthcare REIT position peaked at $422K in Q1 2019.
  • 323 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2020.

Based on Texas Yale Capital Corp's 13F filing for Q1 2020, filed 13 May 2020.